1. Home
  2. SOPH vs TKNO Comparison

SOPH vs TKNO Comparison

Compare SOPH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$8.61

Market Cap

462.3M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$7.43

Market Cap

268.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
TKNO
Founded
2011
1996
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.3M
268.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SOPH
TKNO
Price
$8.61
$7.43
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
500.8K
255.4K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
N/A
N/A
Revenue
N/A
$40,520,000.00
Revenue This Year
$23.09
$8.27
Revenue Next Year
$19.57
$13.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.35
52 Week Low
$3.10
$1.91
52 Week High
$8.85
$7.84

Technical Indicators

Market Signals
Indicator
SOPH
TKNO
Relative Strength Index (RSI) 71.28 68.89
Support Level $4.63 $4.87
Resistance Level N/A $7.84
Average True Range (ATR) 0.44 0.63
MACD 0.09 0.04
Stochastic Oscillator 84.06 85.10

Price Performance

Historical Comparison
SOPH
TKNO

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Share on Social Networks: